Skip to main content
NCBI home page
Gut logoLink to Gut
. 1989 Jul;30(7):1020–1024. doi: 10.1136/gut.30.7.1020

Clinical response to the long acting somatostatin analogue SMS 201-995 in a child with congenital microvillus atrophy.

R T Couper 1, A Berzen 1, G Berall 1, P M Sherman 1
PMCID: PMC1434271  PMID: 2759484

Abstract

A 27 month old girl with congenital microvillus atrophy received two courses of SMS 201-995, a synthetic long acting analogue of native somatostatin, in an attempt to decrease profuse secretory diarrhoea. During the first trial at 13 months of age fluid and electrolytes administered by parenteral infusion were decreased as measured by water and faecal electrolyte losses. During the second trial of SMS 201-995 at 19 months fluid and electrolyte input were held constant for 14 days. Stool volume declined from 275 ml/kg to 161 ml/kg. Reductions in output of stool electrolytes (Na+, K+, Cl-) were accompanied by an increase in urine fluid output and increased excretion of urinary Na+. Subsequent administration of SMS 201-995 for a nine month period was not associated with adverse side effects or an impairment of growth velocity. These findings suggest that SMS 201-995 may be useful therapy in infants with high output diarrhoea as a result of congenital microvillus atrophy.

Full text

PDF
1020

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bloom S. R., Polak J. M. Somatostatin. Br Med J (Clin Res Ed) 1987 Aug 1;295(6593):288–290. doi: 10.1136/bmj.295.6593.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Davidson G. P., Cutz E., Hamilton J. R., Gall D. G. Familial enteropathy: a syndrome of protracted diarrhea from birth, failure to thrive, and hypoplastic villus atrophy. Gastroenterology. 1978 Nov;75(5):783–790. [PubMed] [Google Scholar]
  3. Drumm B., Cutz E., Tomkins K. B., Cook D., Hamilton J. R., Sherman P. Urogastrone/epidermal growth factor in treatment of congenital microvillous atrophy. Lancet. 1988 Jan 16;1(8577):111–112. doi: 10.1016/s0140-6736(88)90303-0. [DOI] [PubMed] [Google Scholar]
  4. Dudl R. J., Anderson D. S., Forsythe A. B., Ziegler M. G., O'Dorisio T. M. Treatment of diabetic diarrhea and orthostatic hypotension with somatostatin analogue SMS 201-995. Am J Med. 1987 Sep;83(3):584–588. doi: 10.1016/0002-9343(87)90777-7. [DOI] [PubMed] [Google Scholar]
  5. Dueno M. I., Bai J. C., Santangelo W. C., Krejs G. J. Effect of somatostatin analog on water and electrolyte transport and transit time in human small bowel. Dig Dis Sci. 1987 Oct;32(10):1092–1096. doi: 10.1007/BF01300194. [DOI] [PubMed] [Google Scholar]
  6. Jaros W., Biller J., Greer S., O'Dorisio T., Grand R. Successful treatment of idiopathic secretory diarrhea of infancy with the somatostatin analogue SMS 201-995. Gastroenterology. 1988 Jan;94(1):189–193. doi: 10.1016/0016-5085(88)90629-4. [DOI] [PubMed] [Google Scholar]
  7. Koelz A., Kraenzlin M., Gyr K., Meier V., Bloom S. R., Heitz P., Stalder H. Escape of the response to a long-acting somatostatin analogue (SMS 201-995) in patients with VIPoma. Gastroenterology. 1987 Feb;92(2):527–531. doi: 10.1016/0016-5085(87)90153-3. [DOI] [PubMed] [Google Scholar]
  8. O'Shaughnessy D. J., Long R. G., Adrian T. E., Christofides N. D., Ghatei M. A., Sarson D. L., Bloom S. R. Somatostatin-14 modulates postprandial glucose levels and release of gastrointestinal and pancreatic hormones. Digestion. 1985;31(4):234–242. doi: 10.1159/000199205. [DOI] [PubMed] [Google Scholar]
  9. Ohlbaum P., Galperine R. I., Demarquez J. L., Vergnes P., Martin C. Use of a long-acting somatostatin analogue (SMS 201-995) in controlling a significant ileal output in a 5-year-old child. J Pediatr Gastroenterol Nutr. 1987 May-Jun;6(3):466–470. doi: 10.1097/00005176-198705000-00026. [DOI] [PubMed] [Google Scholar]
  10. Olsen J. A., Loud F. B., Christiansen J. Inhibition of meal stimulated gastric acid secretion by an octapeptide somatostatin analogue SMS 201-995. Gut. 1987 Apr;28(4):464–467. doi: 10.1136/gut.28.4.464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Phillips A. D., Jenkins P., Raafat F., Walker-Smith J. A. Congenital microvillous atrophy: specific diagnostic features. Arch Dis Child. 1985 Feb;60(2):135–140. doi: 10.1136/adc.60.2.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Roy D. R. Acute effect of salmon calcitonin on renal magnesium transport in the magnesium-loaded rat. Can J Physiol Pharmacol. 1986 Jan;64(1):66–71. doi: 10.1139/y86-010. [DOI] [PubMed] [Google Scholar]
  13. Ruskoné A., René E., Chayvialle J. A., Bonin N., Pignal F., Kremer M., Bonfils S., Rambaud J. C. Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera. Dig Dis Sci. 1982 May;27(5):459–466. doi: 10.1007/BF01295657. [DOI] [PubMed] [Google Scholar]
  14. Smith S. S., Shulman D. I., O'Dorisio T. M., McClenathan D. T., Borger J. A., Bercu B. B., Root A. W. Watery diarrhea, hypokalemia, achlorhydria syndrome in an infant: effect of the long-acting somatostatin analogue SMS 201-995 on the disease and linear growth. J Pediatr Gastroenterol Nutr. 1987 Sep-Oct;6(5):710–716. [PubMed] [Google Scholar]
  15. Williams N. S., Cooper J. C., Axon A. T., King R. F., Barker M. Use of a long acting somatostatin analogue in controlling life threatening ileostomy diarrhoea. Br Med J (Clin Res Ed) 1984 Oct 20;289(6451):1027–1028. doi: 10.1136/bmj.289.6451.1027. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES